Everest Group, Ltd. (EG) — Q2 2026 Earnings Preview

Company

Everest Group, Ltd.

Ticker

NYSE: EG

Reporting Period

Q2 2026 (quarter ended June 30, 2026)

Earnings Date

July 29–30, 2026

Prepared Date

July 28, 2026

Sector ETF Benchmark

IAK (iShares U.S. Insurance ETF)

1. Earnings Preview

Key Takeaway: Setup is constructive but not clean — the bar is beatable on underwriting (consensus combined ratio of ~92.0% vs. EG’s Q1 2026 actual of 91.2%), but the single biggest swing factor is whether the Baltimore Bridge reserve development materializes in Q2 (management flagged “a few tens of millions” of incremental prior-year development possible in Q2 or Q3) and how much property cat pricing softness flows through net premium written.

Heading into Q2 2026, Everest’s setup is one of improving underlying quality against a backdrop of deliberate top-line contraction and a still-uncertain cat reserve item. Consensus operating EPS of $14.74 represents a meaningful step-down from Q1’s $16.08 actual, largely reflecting the absence of the outsized alternative investment income that boosted Q1, and the bar on net premium written ($3.37B consensus) is already discounting the ongoing casualty runoff and retail exit — making a volume beat less likely but also less necessary. Management’s tone on the Q1 call was confident on underwriting trajectory (attritional combined ratio improving 3.8 pts in GW&S to 58.9%) while explicitly cautious on property cat pricing (rates down 13% at April 1, mid-teens declines expected at 6/1 Florida), and the launch of the Annapurna Re casualty sidecar ($600M third-party capital) signals conviction in the casualty book’s quality. Estimate revisions have been modestly positive since the Q1 print — FY2026 operating EPS consensus moved from $53.19 to $51.50 (a slight downward drift), while the stock has rallied ~15.9% since last earnings vs. IAK +15.7% and SPY +4.1%, suggesting the market has already priced in meaningful execution progress. The wildcard is the Baltimore Bridge: management guided to “a few tens of millions” of incremental prior-year development in Q2 or Q3, and peer RenaissanceRe (RNR) confirmed in its Q2 2026 call that the industry loss estimate grew materially, with RNR itself booking 4.1 points of adverse development from the bridge — this is the most likely source of a negative surprise for EG in Q2.

2. KPIs & Consensus Expectations

Key Takeaway: Consensus is a moderate bar on underwriting (combined ratio ~92.0% vs. Q1 actual 91.2%), but operating EPS ($14.74) is the bigger swing factor given sensitivity to cat activity and alternative investment income. Net premium written is the secondary watch item given ongoing portfolio reshaping.

Table 1 — Q2 2026 Current Quarter Snapshot

KPI

Q1 2026 Actual

Q2 2025 Actual (Prior Year)

Q2 2026 Consensus Estimate

YoY Change

Guidance

Consensus vs. Guidance

Operating EPS (Diluted)

$16.08

$17.56

$14.74

-16.1%

No specific Q2 guidance; FY2026 implied ~$51.50

N/A (no quarterly guide)

Combined Ratio (%)

91.2%

90.4%

92.0%

+160 bps

Legacy >110% for FY2026; GW&S targeting low-90s

Broadly in line with guidance range

Net Premium Written

$3.186B

$4.119B

$3.367B

-18.3%

No specific quarterly guide; FY2026 ~$13.14B

N/A (no quarterly guide)

Net Investment Income

$567M

$532M

$496M

-6.8%

Flat to marginal AUM growth; ~$60M annual drag from ADC

Consensus below prior year; reflects ADC drag

Attritional Combined Ratio (%)

88.5%

88.4%

88.8%

+40 bps

GW&S targeting lower-90s; Reinsurance improving

Broadly in line

Total Cat Loss Ratio (%)

3.6%

0.5%

3.2%

+270 bps

Cat load ~7% annually; Q2 typically lower cat quarter

Consensus below annual load; assumes benign Q2

Total Revenues

$4.068B

$4.492B

$4.033B

-10.2%

Declining due to retail exit; FY2026 ~$15.95B

Consensus reflects deliberate top-line contraction

Source: Visible Alpha consensus and actuals data. All consensus figures as of July 28, 2026.

Table 2 — Beat/Miss History: Operating EPS & Combined Ratio (Last 8 Quarters)

Quarter

Op. EPS Reported

Op. EPS Consensus

EPS Surprise %

EPS Result

Comb. Ratio Reported

Comb. Ratio Consensus

CR Surprise

Q1 2026

$16.08

$13.95

+15.3%

BEAT

91.2%

92.9%

Better (170 bps)

Q4 2025

$13.24

$13.61

-2.7%

MISS

98.4%

96.5%

Worse (190 bps)

Q3 2025

$7.55

$14.58

-48.2%

MISS

103.4%

92.9%

Worse (1050 bps)

Q2 2025

$17.56

$15.00

+17.1%

BEAT

90.4%

91.9%

Better (150 bps)

Q1 2025

$6.45

$7.63

-15.5%

MISS

102.7%

101.4%

Worse (130 bps)

Q4 2024

-$18.39

-$16.06

N/M (large loss qtr)

MISS

135.5%

134.0%

Worse (150 bps)

Q3 2024

$14.62

$12.08

+21.0%

BEAT

93.1%

96.3%

Better (320 bps)

Q2 2024

$16.85

$16.66

+1.1%

BEAT

90.3%

89.7%

Worse (60 bps)

Source: Visible Alpha consensus and actuals data.

Pattern: EG has beaten operating EPS in 4 of the last 8 quarters, with misses concentrated in quarters with elevated catastrophe or reserve charges (Q4 2024, Q3 2025, Q1 2025); the two most recent clean quarters (Q2 2025, Q1 2026) were both significant beats, suggesting the underlying business is tracking above consensus when cat/reserve noise is absent.

3. Guidance & Commentary Evolution

Key Takeaway: No formal guidance revisions since the Q1 2026 earnings call (April 29, 2026), but the launch of Annapurna Re (June 17) and the Colombia sale announcement (May 19) represent meaningful strategic updates. Management tone remains confident on underwriting trajectory while explicitly cautious on property cat pricing and Baltimore Bridge reserve development.

Metric

Initial Guidance (Q1 2026 Earnings Call, Apr 29)

Revised Guidance

Current Consensus

Note

Share Repurchase Floor (Quarterly)

Raised to $300M/quarter (from $200M), effective Q2 2026, absent major external dislocation

Elevated payout ratio expected for FY2026

↑ Raised at Q1 earnings call; signals strong conviction stock is undervalued

Legacy Segment Combined Ratio (FY2026)

>110% for FY2026, driven by retail-to-AIG transition expenses

~135% in Q4 2024; improving but still elevated

Unchanged; ~$150M restructuring charges expected throughout 2026

Underwriting Expense Ratio (Group)

6%–7% range for FY2026; not expected below 6% for any meaningful period

GW&S operating expense ratio at 12.6% in Q1; expected to improve as business scales

Unchanged; elevated real estate costs expected in Q4 2026

Operating Tax Rate (FY2026)

17%–18% working assumption for full year (Q1 actual was 11.7%, below guidance)

N/A — not separately tracked in VA

Unchanged; Q1 benefited from discrete tax items

Property Cat Pricing (6/1 Florida Renewals)

Mid-teens rate declines expected at 6/1 Florida; terms and conditions expected to hold; returns remain above thresholds

Peer RNR confirmed high-teens declines at mid-year; broadly consistent with EG guidance

Unchanged; RNR Q2 2026 call confirmed pricing pressure consistent with EG’s April guidance

Baltimore Bridge Reserve Development

Initial reserve $70M; “a few tens of millions” of incremental development possible in Q2 or Q3 via prior-year development line

N/A — not in VA consensus

⚠ Key risk: RNR booked 4.1 pts adverse development from bridge in Q2 2026; EG may follow

Capital Release from Retail Exit (AIG Transaction)

Meaningful capital release expected to become visible in H2 2026; Canada sale ~6 months from close

Colombia operations sale to AIG announced May 19, 2026 (expected close early 2027)

↑ Colombia sale (May 19) adds another retail exit step; accretive to capital return discussion

Net Investment Income / AUM Growth

Flat to marginal AUM growth; ~$60M annual NII drag from ADC transaction

$496M Q2 2026 consensus (vs. $567M Q1 2026 actual)

Unchanged; Q1 NII was boosted by outsized alternative investment returns (not expected to repeat)

4. Guidance vs. Estimate Revision Tracker

Key Takeaway: FY2026 operating EPS estimates have drifted modestly lower since the Q1 print (from $53.19 to $51.50, -3.2%), while Q2 2026 estimates are essentially flat since the post-Q1 baseline. The gap between current consensus and management’s implied FY guidance is not alarming, but the downward drift in FY EPS reflects the market pricing in the ADC-related NII drag and continued top-line contraction from the retail exit.

KPI & Period

Estimate ~5 Days Post Q1 Earnings (as of May 6, 2026)

Current Consensus (Jul 28, 2026)

Estimate Δ (%)

Initial Guidance (Q1 2026 Call)

Current Guidance

Guidance Δ

Consensus vs. Guidance (%)

Op. EPS — Q2 2026

$14.63

$14.74

+0.8%

No quarterly guide

No quarterly guide

N/A

N/A

Op. EPS — FY2026

$53.19

$51.50

-3.2%

No formal FY EPS guide; implied ~$51–$57 range from analyst models

Unchanged

N/A

N/A

Combined Ratio — Q2 2026

92.4%

92.0%

-40 bps

No quarterly guide; GW&S targeting low-90s

Unchanged

N/A

Broadly in line

Combined Ratio — FY2026

94.6%

94.8%

+20 bps

Legacy >110%; GW&S low-90s; Reinsurance improving

Unchanged

N/A

Broadly in line

Net Premium Written — Q2 2026

$3.552B

$3.367B

-5.2%

No quarterly guide; FY2026 ~$13.14B

Unchanged

N/A

N/A

Net Premium Written — FY2026

$13.620B

$13.142B

-3.5%

No formal guide; deliberate casualty runoff + retail exit

Unchanged

N/A

N/A

Net Investment Income — Q2 2026

$505M

$496M

-1.8%

Flat to marginal AUM growth; ~$60M annual ADC drag

Unchanged

N/A

Broadly in line

Source: Visible Alpha consensus and actuals data. Post-Q1 baseline as of May 6, 2026 (5 trading days after April 29, 2026 earnings release).

The modest downward drift in FY2026 EPS (-3.2%) and NPW (-3.5%) since the Q1 print reflects the market incorporating the ADC-related NII headwind and continued top-line contraction from the retail exit, rather than any deterioration in underlying underwriting quality. Combined ratio estimates have been essentially stable, consistent with management’s guidance for improving attritional performance.

5. Stock Performance

Key Takeaway: EG has rallied ~15.9% since the Q1 2026 earnings date (April 29, 2026), essentially in line with the insurance sector (IAK +15.7%) but well ahead of the S&P 500 (+4.1%), suggesting the re-rating has been sector-driven rather than EG-specific alpha. The stock’s recovery from a mid-May/early-June trough (driven by property cat pricing concerns) was catalyzed by the Annapurna Re sidecar launch and multiple analyst price target upgrades in early July.

EG vs. IAK (iShares U.S. Insurance ETF) vs. S&P 500 — Indexed to 100 at April 29, 2026 (Q1 2026 Earnings Date). Source: Yahoo Finance.

Key events since Q1 2026 earnings (April 29, 2026):

Analyst Consensus (as of July 28, 2026): 16 analysts covering EG; consensus rating Hold (12 Hold, 4 Buy, 0 Sell). Average price target ~$375–$388 (range: $287–$484). Stock at ~$398.70 (July 29 pre-market) is trading above the consensus price target, suggesting the market is pricing in a beat or further re-rating.

6. Material News & Developments

Key Takeaway: The most important development since Q1 earnings is the launch of Annapurna Re (June 17), which signals third-party investor confidence in Everest’s casualty underwriting quality and expands the capital-light earnings model — a direct positive read-through for Q2 and beyond. The Baltimore Bridge reserve development remains the key downside risk to watch in the Q2 print.

7. Peer Commentaries — Last 60 Days (Q2 2026 Read-Throughs)

Key Takeaway: Peer commentary from the last 60 days is broadly constructive for EG’s Q2 setup: property cat pricing softened as expected (high-teens at mid-year, consistent with EG’s April guidance), underwriting discipline is holding on terms and conditions, and casualty reserve trends are mixed but manageable. The Baltimore Bridge is the most consistent negative read-through across peers. RNR’s Q2 2026 call (July 23) is the most directly relevant, as it covers the same reporting quarter as EG.

Note on peer selection: Only commentary about Q2 2026 conditions or forward-looking statements made after Q1 2026 earnings is included. Q1 2025 results commentary has been excluded. RNR reported Q2 2026 on July 23, 2026 (same quarter as EG). HG and SPNT reported Q1 2026 in May 2026 but provided forward-looking commentary about Q2 2026 and mid-year renewals.

RenaissanceRe (RNR) — Q2 2026 Earnings Call (July 23, 2026)

Relevance: RNR is EG’s closest pure-play reinsurance peer and reported Q2 2026 on July 23 — the most timely and directly comparable read-through available. RNR’s commentary covers the same mid-year renewal period and cat environment that will drive EG’s Q2 results.

Hamilton Insurance Group (HG) — Q1 2026 Earnings Call (May 1, 2026)

Relevance: HG provided forward-looking commentary on mid-year renewals and Q2 2026 conditions, including specific guidance on Florida 6/1 renewals and the Middle East conflict impact. HG’s Bermuda-focused reinsurance book overlaps meaningfully with EG’s Reinsurance segment.

SiriusPoint (SPNT) — Q1 2026 Earnings Call (May 8, 2026)

Relevance: SPNT provided forward-looking commentary on Q2 2026 and full-year 2026 conditions, including specific guidance on property cat pricing, casualty reserve trends, and combined ratio trajectory. SPNT’s diversified reinsurance/insurance model overlaps with EG’s GW&S segment.

Peer Commentary Summary Table

Theme

RNR (Q2 2026, Jul 23)

HG (Q1 2026, May 1)

SPNT (Q1 2026, May 8)

EG Read-Through

Property Cat Pricing

High-teens declines; rates broadly adequate; grew limit

Similar pressure to YTD; margins above thresholds; T&C holding

~15% declines; Q1 was most extreme shrinkage; improving H2

Neutral-to-positive: pricing soft but adequate; EG’s discipline should protect margins

Baltimore Bridge

4.1 pts adverse development in Q2; $12M net impact

$14M adverse development in Q1 (2.4 pts)

No significant impact noted

Negative: EG likely books $20–50M incremental development in Q2

Casualty Reserves

Cautious; social inflation ongoing; favorable ex-bridge

Favorable history; no material casualty issues

20 consecutive quarters favorable; prudent approach

Neutral: EG’s ADC provides finality; underlying casualty improving

Combined Ratio Trend

72% adjusted; strong property cat accident year

89.8% group; dramatic improvement from Q1 2025

88.9% core; lowest in 6 quarters; 14th consecutive underwriting profit

Positive: sector-wide attritional improvement supports EG’s ~92% Q2 consensus

Middle East / Iran

Not specifically called out in Q2

Manageable; losses to continue; inflationary risk

Minimal claims noted

Watch: EG has $58M Q1 provision; incremental Q2 exposure possible

Capital / Sidecars

Chose not to deploy Epsilon at mid-year; ceded 35% of C&S gross premium

$300M casualty sidecar launched in Q1

$135M buyback authorization remaining; may use special dividend

Positive: EG’s $600M Annapurna Re is sector-leading; $300M/qtr buyback floor

8. Insider Transaction Activity

Key Takeaway: The only open-market sale since Q1 earnings was a small discretionary sale by Jason Keen (EVP & CEO of GW&S Division) of 775 shares on May 7 — modest in size and not a meaningful signal. Director share awards (transaction code ‘A’) are routine compensation grants, not open-market purchases. No clustered open-market buys or unusual sale activity; insider activity is quiet heading into Q2 earnings.

Name

Title

Transaction Type

Shares / Value

Transaction Date

Note

Jason Keen

EVP & CEO, GW&S Division

Open Market Sale

775 shares / ~$272,676 (avg. $351.84/sh)

May 7, 2026

Discretionary sale; small relative to 8,170 shares remaining post-sale; not a significant signal

Elias F. Habayeb

EVP & CFO

Award (Compensation Grant)

21,098 shares awarded

May 12, 2026

Routine equity compensation grant to new CFO; not an open-market purchase

Meryl D. Hartzband

Director

Award (Compensation Grant)

86 shares awarded

July 1, 2026

Routine director equity compensation; not an open-market purchase

John M. Howard

Director

Award (Compensation Grant)

86 shares awarded

July 1, 2026

Routine director equity compensation; not an open-market purchase

Allan Levine

Director

Award (Compensation Grant)

86 shares awarded

July 1, 2026

Routine director equity compensation; not an open-market purchase

Source: SEC Form 4 filings via insider transaction data.

No open-market buys have been filed by insiders since Q1 2026 earnings. The only open-market sale (Jason Keen, 775 shares) is small and not a meaningful bearish signal. The absence of insider buying is notable given management’s stated conviction that the stock is undervalued — though the company’s own $300M/quarter buyback program is the primary vehicle for expressing that conviction.